Crossmark

Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients

Crossref DOI link: https://doi.org/10.1186/s13046-022-02259-8

Published Online: 2022-02-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fina, Emanuela https://orcid.org/0000-0002-9837-4320
Cleris, Loredana

Dugo, Matteo

Lecchi, Mara

Ciniselli, Chiara Maura

Lecis, Daniele

Bianchi, Giulia Valeria

Verderio, Paolo

Daidone, Maria Grazia

Cappelletti, Vera
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (IG 16900)

Fondazione Italiana per la Ricerca sul Cancro (Fellowship 16411)

Fondazione Umberto Veronesi (Postdoctoral fellowships)
License Information

Text and Data Mining valid from 2022-02-25

Version of Record valid from 2022-02-25
More Information

Article History

Received: 2 December 2021

Accepted: 17 January 2022

First Online: 25 February 2022

Declarations

:

: Observational clinical studies were approved by the Ethics Committee of IRCCS Istituto Nazionale dei Tumori and carried out in accordance with the Declaration of Helsinki and the STROBE guidelines. Animal studies were approved by the Institutional Animal Care and Use Committee of IRCCS Istituto Nazionale dei Tumori and by the Italian Ministry of Health and carried out following the ARRIVE guidelines.

: Not applicable

: The Authors declare no potential conflicts of interest but the following competing interest: GVB is Advisory Board Member for Novartis, Eli Lilly and Roche.

Document is current

Any future updates will be listed below